ArticleClinical cancer research : an official journal of the American Association for Cancer Research2015

MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer.

Celina García-García et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.